Clinical Trials Browser

Terminated × Urinary Bladder Neoplasms × Everolimus × Clear all

NCT01215136 2023-11-24

First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma

Phase 2 Terminated

36 enrolled 14 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00933374 2015-03-18

RAD001

Phase 2 Terminated

Urinary Bladder Neoplasms